Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease.

CONCLUSION: IS may have a critical role in the prediction of CV disease in patients with CKD. Further large-scale investigations are warranted and suggested.
PMID: 30928187 [PubMed - as supplied by publisher]

Source: J Formos Med Assoc - March 27, 2019 Category: General Medicine Authors: Fan PC, Chang JC, Lin CN, Lee CC, Chen YT, Chu PH, Kou G, Lu YA, Yang CW, Chen YC Tags: J Formos Med Assoc Source Type: research